Asbestos-tainted talc killed 30-year-old lawyer, jury told

25 May 2018 by under Legal

Talc truth 100x100 Asbestos tainted talc killed 30 year old lawyer, jury toldBertila Boyd-Bostic would be alive today if the baby powder she used on her body every day since she was born wasn’t contaminated with asbestos, the attorney representing her estate and her husband, Antoine Bostic, told a South Carolina jury. The in the baby powder Boyd-Bostic used caused her to develop an extremely rare form of cancer, which took her life at just 30 years of age, the lawyer argued.

Boyd-Bostic and her husband, who were both attorneys, sued 15 companies in May 2017, just months after she was diagnosed with pericardial mesothelioma. The lawsuit named companies like , makers of Johnson’s Baby Powder. She died in May 2017.

Mesothelioma is a rare type of cancer that develops in the lining of organs, typically the lungs. Pericardial mesothelioma affects the lining of the heart, and is extremely rare with only a handful of cases diagnosed annually. All forms of malignant mesothelioma are deadly, typically within 12 to 24 months after diagnosis. The disease is caused by asbestos exposure.

Johnson & Johnson is fighting the claims that its talc contains asbestos, and even pointed out that asbestos is typically associated with pleural mesothelioma, the type of mesothelioma that affects the lungs. The type of mesothelioma that Boyd-Bostic had was not known to be caused by asbestos, the consumer health care giant argued.

The Boyd-Bostic trial comes just a month after a New Jersey jury hit Johnson & Johnson and its talc supplier with a combined $117 million in compensatory and punitive damages in a case brought by a man who claimed his regular use of Johnson’s Baby Powder caused him to develop pleural mesothelioma. In late May, a California jury awarded a total of $25.7 million in compensatory and punitive damages to a woman who claimed her mesothelioma was caused by regular use of Johnson & Johnson’s talc-containing products.

Source: Law360

Comments are closed.